1El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014; 63(6):871-880.
2Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Färkkilä M.l. GERD: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000;61:6-13.
3Vaezi M, Zehrai A, Yuksel E. Testing for refractory gastroesophageal reflux disease. ASGE Leading Edge. 2012;2(2):1-13.
4Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290:66-72.
5Richter J, Pandolfino J, Vela M, et al. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group. Dis Esophagus. 2013;26(8):755-65.
6Herregods TV, Troelstra M, Weijenborg PW, Bredenoord AJ, Smout AJ. Patients with refractory reflux symptoms often do not have GERD: Neurogastroenterol Motil. 2015;27(9): 1267-1273.
7Dymedex Market Development Consulting, Strategic Market Assessment, GERD, 30 de outubro de 2014. Referências 1-3, 6-15, 22, 23, 25 e 34 da lista de citação completa, acesse http://www.medtronic.com/giclaims
8SEER Cancer Statistics Factsheets: Esophageal Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/esoph.html
9Spechler S. et al. Barrett’s Esophagus. N Engl J Med 2014; 371:836-45.